Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostate-specific antitumor activity by probasin promoter-directed p202 expression.

Molecular carcinogenesis - 1 Jul 2003

Wen Yong, Giri Dipak, Yan Duen-Hwa, Spohn Bill, Zinner Ralph G, Xia Weiya, Thompson Timothy C, Matusik Robert J, Hung Mien-Chie

Abstract excerpt

p202, an interferon (IFN) inducible protein, arrests cell cycle at G1 phase leading to cell growth retardation. We previously showed that ectopic expression of p202 in human prostate cancer cells renders growth inhibition and suppression of transformation phenotype in vitro. In this report, we showed that prostate cancer cells with stable expression of p202 were less tumorigenic than the parental cells. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cdc20 Proteins
Share to Cyclin B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin B1

Share to Immunoenzyme Techniques

Share to Liposomes

Share to Neoplasms, Experimental

Share to Retinoblastoma Protein

Share to Tumor Suppressor p53-Binding Protein 1

Source

Identifiers

PMID: 12884364
DOI: 10.1002/mc.10129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Prostate-specific antitumor activity by probasin promoter-directed p202 expression.PMID 12884364Read ↗

Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202.Semantic proximity Read ↗

Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.Semantic proximity Read ↗

Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progressionSemantic proximity Read ↗

AIM2 suppresses human breast cancer cell proliferation <i>in vitro</i> and mammary tumor growth in a mouse modelSemantic proximity Read ↗

Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model.Semantic proximity Read ↗

Microarray analysis reveals potential target genes of NF‐κB2/p52 in LNCaP prostate cancer cellsSemantic proximity Read ↗

Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis.Semantic proximity Read ↗

MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancerSemantic proximity Read ↗

Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.Semantic proximity Read ↗

The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.